Therapeutic focus areas
PeterBio develops innovative gene and cell therapies to fight diseases. We develop treatments that are safe and effective, and focus to treat and prevent gene related diseases. Our priority is to help as many people as possible.
Our current priority is gene-correction in monogenic diseases. Benefiting from our enhanced safety profile, we not only look at acute life-threatening diseases, but also develop approaches for more chronic diseases that have a strong genetic component, such as Alzheimer’s Disease, Sickle Cell Disease and Muscular Dystrophy. Also, we look at RITDM to develop next generation immune-oncology applications.Learn more